Literature DB >> 21562920

Low investigation rate for adrenal incidentalomas.

S Bujawansa, D Bowen-Jones.   

Abstract

The prevalence of adrenal incidentaloma has increased with the increasing use of imaging techniques. While majority are benign adenoma, a small but significant minority may be primary adrenal carcinoma or have endocrine hyper secretion. Existing guidance suggests that excess catecholamine and cortisol secretion should be ruled out in all cases and excess aldosterone secretion should be ruled out in hypertensive patients. Repeat evaluation after a period of time is also suggested. We have reviewed the management of adrenal incidentaloma in a large district general hospital in the North West of England.

Entities:  

Mesh:

Year:  2011        PMID: 21562920     DOI: 10.1007/s12020-011-9487-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  8 in total

Review 1.  The clinically inapparent adrenal mass: update in diagnosis and management.

Authors:  Georg Mansmann; Joseph Lau; Ethan Balk; Michael Rothberg; Yukitaka Miyachi; Stefan R Bornstein
Journal:  Endocr Rev       Date:  2004-04       Impact factor: 19.871

Review 2.  Clinical practice. The incidentally discovered adrenal mass.

Authors:  William F Young
Journal:  N Engl J Med       Date:  2007-02-08       Impact factor: 91.245

3.  American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations.

Authors:  Martha A Zeiger; Geoffrey B Thompson; Quan-Yang Duh; Amir H Hamrahian; Peter Angelos; Dina Elaraj; Elliott Fishman; Julia Kharlip
Journal:  Endocr Pract       Date:  2009 Jul-Aug       Impact factor: 3.443

4.  Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.

Authors:  Iacopo Chiodini; Valentina Morelli; Antonio Stefano Salcuni; Cristina Eller-Vainicher; Massimo Torlontano; Francesca Coletti; Laura Iorio; Antonello Cuttitta; Angelo Ambrosio; Leonardo Vicentini; Fabio Pellegrini; Massimiliano Copetti; Paolo Beck-Peccoz; Maura Arosio; Bruno Ambrosi; Vincenzo Trischitta; Alfredo Scillitani
Journal:  J Clin Endocrinol Metab       Date:  2010-04-07       Impact factor: 5.958

5.  Adrenal lesion frequency: A prospective, cross-sectional CT study in a defined region, including systematic re-evaluation.

Authors:  Lilian Hammarstedt; Andreas Muth; Bo Wängberg; Lena Björneld; Helga A Sigurjónsdóttir; Galina Götherström; Erik Almqvist; Håkan Widell; Sture Carlsson; Stefan Ander; Mikael Hellström
Journal:  Acta Radiol       Date:  2010-10-25       Impact factor: 1.990

Review 6.  Approach to the patient with an adrenal incidentaloma.

Authors:  Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

Review 7.  NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma").

Authors: 
Journal:  NIH Consens State Sci Statements       Date:  2002 Feb 4-6

8.  Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?

Authors:  T J Cawood; P J Hunt; D O'Shea; D Cole; S Soule
Journal:  Eur J Endocrinol       Date:  2009-05-13       Impact factor: 6.664

  8 in total
  7 in total

1.  Inhibition of aldehyde reductase by acidic metabolites of the biogenic amines.

Authors:  A J Turner; P E Hick
Journal:  Biochem Pharmacol       Date:  1975-09-15       Impact factor: 5.858

2.  Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma.

Authors:  Gianluca Iacobellis; Luigi Petramala; Giuseppe Barbaro; Atil Y Kargi; Valentina Serra; Laura Zinnamosca; Luciano Colangelo; Cristiano Marinelli; Antonio Ciardi; Giorgio De Toma; Claudio Letizia
Journal:  Endocrine       Date:  2013-02-21       Impact factor: 3.633

3.  Accuracy of focal cystic appearance within adrenal nodules on contrast-enhanced CT to distinguish pheochromocytoma and malignant adrenal tumors from adenomas.

Authors:  Michael T Corwin; Ana S Mitchell; Machelle Wilson; Michael J Campbell; Ghaneh Fananapazir; Thomas W Loehfelm
Journal:  Abdom Radiol (NY)       Date:  2021-01-08

4.  Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden.

Authors:  Henrik Olsen; Erik Nordenström; Anders Bergenfelz; Ulf Nyman; Stig Valdemarsson; Erik Palmqvist
Journal:  Endocrine       Date:  2012-02-17       Impact factor: 3.633

5.  Can abdominal CT features predict autonomous cortisol secretion in patients with adrenal nodules?

Authors:  Michael T Corwin; Christopher Lan; Machelle Wilson; Thomas W Loehfelm; Michael J Campbell
Journal:  Abdom Radiol (NY)       Date:  2021-05-07

6.  The impact of an adrenal incidentaloma algorithm on the evaluation of adrenal nodules.

Authors:  Leslie S Eldeiry; Marina M Alfisher; Catherine F Callahan; Nancy N Hanna; Jeffrey R Garber
Journal:  J Clin Transl Endocrinol       Date:  2018-07-05

7.  Is Preoperative Biochemical Testing for Pheochromocytoma Necessary for All Adrenal Incidentalomas?

Authors:  Joo Hyun Jun; Hyun Joo Ahn; Sangmin M Lee; Jie Ae Kim; Byung Kwan Park; Jee Soo Kim; Jung Han Kim
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.